Dermatology Journal Articles

• The Use of Fetal Bovine Collagen on Chronic Wounds A new study examines the effects of a fetal bovine collagen on limb salvage in chronic wounds.
  Wounds, May 20, 2022
• MIS in Children After SARS-CoV-2 Vaccination Does COVID-19 vaccination play a role in the pathogenesis of multisystem inflammatory syndrome in children? This report helps further our understanding.
  Emerging Infectious Diseases, May 20, 2022
• Safety of IV Golimumab in RA, PsA, and AS A pooled analysis of data from three trials provides insight into the safety profile of IV golimumab for the treatment of these rheumatologic conditions.
  Arthritis Research & Therapy, May 18, 2022
• Non-Pharmacological Treatment of Systemic Sclerosis Symptoms When it comes to the treatment of these symptoms in patients with systemic sclerosis, what are the non-pharmacologic options? This article provides evidence-based recommendations.
  Rheumatology, May 18, 2022
• Cyanoacrylate Skin Protectant for Skin Damage in Children The application of a cyanoacrylate liquid skin protectant is a safe and effective option for managing skin damage in infants and children.
  Wounds, May 13, 2022
• Effectiveness of BNT162b2 Vaccine Booster Against SARS-CoV-2 How effective is this booster dose against SARS-CoV-2 infection and complications in breakthrough cases?
  Emerging Infectious Diseases, May 13, 2022
• Risk of Herpesvirus and Serious Infections in Atopic Dermatitis This study suggests that atopic dermatitis is associated with an increased risk of hospital admission with infections, opportunistic infections and herpesvirus infections in both children and adults.
  The British Journal of Dermatology, May 10, 2022
• Outcomes Among Adults With SARS-CoV-2 Infection Delta/Omicron This CDC report reaffirms that COVID-19 vaccination, particularly a booster dose, continues to be critical in mitigating the health care burden of the Omicron variant.
  Morbidity & Mortality Weekly Report, May 09, 2022
• Quality Care and Implications for the Limb Salvage Center The development and implementation of collaborative quality initiatives could help improve outcomes in chronic wound care.
  Wounds, May 06, 2022
• Autologous Fat Grafting in Plastic Surgery This article provides an overview of the history of autologous fat grafting and discusses the evolution of this technique.
  ePlasty, May 03, 2022
• Bimekizumab for Moderate-to-severe Plaque Psoriasis Bimekizumab, which selectively inhibits both interleukin-17A and IL-17F, is currently under investigation for treatment of moderate-to-severe psoriasis. What is the best dosing interval?
  The British Journal of Dermatology, May 03, 2022
• Breast Implant Illness: Capsulectomy and Implant Removal Patients experiencing symptoms of breast implant illness could be successfully treated with implant removal with capsulectomy.
  ePlasty, April 26, 2022
• Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa This review discusses the principles of gene therapy and its application to recessive dystrophic epidermolysis bullosa, the most debilitating variant of EB. Where does current research stand?
  The British Journal of Dermatology, April 26, 2022
• Dermal Regeneration Template in Hidradenitis Reconstruction Patients who underwent axillary hidradenitis reconstruction with a dermal regeneration template and skin grafting realized complete healing with no complications.
  Wounds, April 22, 2022
• Vaccine-Associated Encephalitis in Immunocompromised Child This report describes a rare case of an immunocompromised child who developed measles encephalitis after receiving an MMR vaccine.
  Emerging Infectious Diseases, April 20, 2022
• Third mRNA Vaccine in Preventing COVID-19 Hospitalization According to this CDC report, a third dose of an mRNA COVID-19 vaccine significantly increases effectiveness against hospitalization among adults without and with immunocompromising conditions.
  Morbidity & Mortality Weekly Report, April 18, 2022
• Long-term Safety of Risankizumab in Plaque Psoriasis The safety findings in this analysis support risankizumab as a long-term treatment option for patients with moderate-to-severe psoriasis.
  The British Journal of Dermatology, April 18, 2022
• Cytokine Signatures Differentiate Systemic Sclerosis for PAH Find out how serum cytokine signatures could help identify which systemic sclerosis patients are most at risk for pulmonary arterial hypertension.
  Arthritis Research & Therapy, April 18, 2022
• PRP vs Conventional Dressing for Diabetic Foot Ulcers When it comes to the effective management of diabetic foot ulcers, might the use of autologous platelet-rich plasma offer additional benefits over conventional dressings?
  Wounds, April 15, 2022
• Use of RZV in Immunocompromised Adults Aged >19 Years Recombinant zoster vaccine is the first herpes zoster vaccine approved for use in immunocompromised persons. Review its use in this population in this brief article.
  Morbidity & Mortality Weekly Report, April 11, 2022